Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.
"As we continue to learn about the potential harms and benefits of prenatal cannabis use, clinicians must provide coordinated, nonstigmatizing care and education to support pregnant individuals in making informed decisions about cannabis use," noted study authors.
"I would have done anything to give birth...they could have asked me anything, and I would have almost certainly said yes, as long as it meant getting the baby out" - one participant's revelation from a study showing physical discomfort, not BMI concerns, drove women's choices for early induction.
Study demonstrates dose-dependent relationship: each additional menopausal symptom associated with poorer cognitive function and increased behavioral changes in later life.